{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:08:14Z","timestamp":1793689694723,"version":"4.5.1"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejmech.2022.114161","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T18:32:33Z","timestamp":1643481153000},"page":"114161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development"],"prefix":"10.1016","volume":"231","author":[{"given":"Elham","family":"Ghobadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaz","family":"Saednia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-6621","authenticated-orcid":false,"given":"Saeed","family":"Emami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114161_bib1","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3389\/fmicb.2019.02903","article-title":"A\u00a0new age in molecular diagnostics for invasive fungal disease: are we ready?","volume":"10","author":"Kidd","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejmech.2022.114161_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.15698\/mic2020.06.718","article-title":"Fungal infections in humans: the silent crisis","volume":"7","author":"Kainz","year":"2020","journal-title":"Microb. Cell"},{"key":"10.1016\/j.ejmech.2022.114161_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007964","article-title":"Fungal diseases as neglected pathogens: a wake-up call to public health officials","volume":"14","author":"Rodrigues","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2022.114161_bib4","doi-asserted-by":"crossref","first-page":"100917","DOI":"10.1016\/j.mycmed.2019.100917","article-title":"Cryptococcus and cryptococcosis in Iran during 1969-2019: a systematic review and meta-analysis","volume":"30","author":"Bandalizadeh","year":"2020","journal-title":"J.\u00a0Mycol. Med."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13104-021-05498-8","article-title":"Genetic diversity and antifungal susceptibility of Candida albicans isolates from Iranian HIV-infected patients with oral candidiasis","volume":"14","author":"Tamai","year":"2021","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.ejmech.2022.114161_bib6","doi-asserted-by":"crossref","first-page":"100115","DOI":"10.1016\/j.simyco.2021.100115","article-title":"Aspergillus fumigatus and aspergillosis: from basics to clinics","volume":"100","author":"Arastehfar","year":"2021","journal-title":"Stud. Mycol."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114161_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101279","article-title":"Differentiation of Aspergillus flavus from Aspergillus oryzae targeting the cyp51A gene","volume":"10","author":"Nargesi","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ejmech.2022.114161_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000489474","article-title":"Treatment of chronic pulmonary aspergillosis: current standards and future perspectives","volume":"96","author":"Alastruey-Izquierdo","year":"2018","journal-title":"Respiration"},{"key":"10.1016\/j.ejmech.2022.114161_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkab317","article-title":"When to change treatment of acute invasive aspergillosis: an expert viewpoint","author":"Slavin","year":"2021","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114161_bib10","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1038\/s41598-021-86038-z","article-title":"Identification and in\u00a0vitro antifungal susceptibility of causative agents of onychomycosis due to Aspergillus species in Mashhad, Iran","volume":"11","author":"Xu","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114161_bib11","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1039\/C9CS00556K","article-title":"A\u00a0comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise","volume":"49","author":"Howard","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2022.114161_bib12","doi-asserted-by":"crossref","first-page":"100366","DOI":"10.1016\/j.imu.2020.100366","article-title":"In silico prediction of ATTAF-1 and ATTAF-2 selectivity towards human\/fungal lanosterol 14\u03b1-demethylase using molecular dynamic simulation and docking approaches","volume":"20","author":"Irannejad","year":"2020","journal-title":"Inform. Med. Unlocked"},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib13","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1021\/jm4016284","article-title":"Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility","volume":"57","author":"Cao","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114161_bib15","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/jm051211n","article-title":"Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking","volume":"49","author":"Sheng","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopha.2018.12.009","article-title":"Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases","volume":"110","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2022.114161_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejmech.2019.03.020","article-title":"Current advances of triazole alcohols derived from fluconazole: design, in\u00a0vitro and in silico studies","volume":"170","author":"Emami","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2022.114161_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2016.6558","article-title":"Fluconazole under review","volume":"315","author":"Voelker","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2022.114161_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole resistance in Candida species: a current perspective","volume":"10","author":"Berkow","year":"2017","journal-title":"Infect. Drug Resist."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib20","doi-asserted-by":"crossref","first-page":"126951","DOI":"10.1016\/j.bmcl.2020.126951","article-title":"Design, synthesis, and structure-activity relationship studies of novel triazole agents with strong antifungal activity against Aspergillus fumigatus","volume":"30","author":"Ding","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"Suppl 6","key":"10.1016\/j.ejmech.2022.114161_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/1469-0691.12513","article-title":"Update on antifungal resistance in Aspergillus and Candida","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114161_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/jof7030197","article-title":"Molecular markers of antifungal resistance: potential uses in routine practice and future perspectives","volume":"7","author":"Garcia-Effron","year":"2021","journal-title":"J.\u00a0Fungi."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib23","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.bmc.2004.02.014","article-title":"Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-[2-[4-aryl-piperazin-1-yl]-ethyl]-tetrazol-2-yl\/1-yl)-1-[1,2,4]-triazol-1-yl-butan-2-ol","volume":"12","author":"Upadhayaya","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114161_bib24","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1021\/jo500369y","article-title":"An enantioselective synthesis of the key intermediate for triazole antifungal agents; application to the catalytic asymmetric synthesis of efinaconazole (Jublia)","volume":"79","author":"Tamura","year":"2014","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib25","doi-asserted-by":"crossref","first-page":"104240","DOI":"10.1016\/j.bioorg.2020.104240","article-title":"History of the development of antifungal azoles: a review on structures, SAR, and mechanism of action","volume":"104","author":"Shafiei","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114161_bib26","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4155\/cli.11.137","article-title":"New-generation triazole antifungal drugs: review of the Phase II and III trials","volume":"1","author":"Girmenia","year":"2011","journal-title":"Clin. Invest."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib27","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1080\/00397910802563420","article-title":"Improved chiral synthesis of ravuconazole","volume":"39","author":"Xu","year":"2009","journal-title":"Synth. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114161_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1248\/cpb.43.441","article-title":"Optically active antifungal azoles. V. Synthesis and antifungal activity of stereoisomers of 3-azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2- butanols","volume":"43","author":"Tasaka","year":"1995","journal-title":"Chem. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114161_bib29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1248\/cpb.41.1035","article-title":"Optically active antifungal azoles. I. Synthesis and antifungal activity of (2R,3R)-2-(2,4-difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl)-2-b utanol and its stereoisomers","volume":"41","author":"Tasaka","year":"1993","journal-title":"Chem. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib30","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1248\/cpb.38.2476","article-title":"Triazole antifungals. II. Synthesis and antifungal activities of 3-acyl-4-methyloxazolidine derivatives","volume":"38","author":"Konosu","year":"1990","journal-title":"Chem. Pharm. Bull."},{"issue":"16","key":"10.1016\/j.ejmech.2022.114161_bib31","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/0960-894X(96)00363-0","article-title":"Novel antifungal 2-aryl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity against Aspergillus fumigatus","volume":"6","author":"Dickinson","year":"1996","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114161_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/op0000879","article-title":"Process development of voriconazole:A novel broad -SpectrumTriazole antifungal agent","volume":"5","author":"Butters","year":"2001","journal-title":"Org. Process Res. Dev."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114161_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1128\/JCM.36.1.198-202.1998","article-title":"In\u00a0vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jac\/44.5.697","article-title":"In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients","volume":"44","author":"Ch\u00e1vez","year":"1999","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114161_bib35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/JCM.39.3.954-958.2001","article-title":"In\u00a0vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi","volume":"39","author":"Espinel-Ingroff","year":"2001","journal-title":"J.\u00a0Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib36","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1086\/367933","article-title":"Voriconazole: a new triazole antifungal agent","volume":"36","author":"Saravolatz","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114161_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114161_bib38","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/fmb.11.118","article-title":"Azole resistance in Aspergillus: a growing public health menace","volume":"6","author":"Denning","year":"2011","journal-title":"Future Microbiol."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114161_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1179\/1973947812Y.0000000051","article-title":"Voriconazole in clinical practice","volume":"24","author":"Mikulska","year":"2012","journal-title":"J.\u00a0Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/ml300429p","article-title":"Discovery of a novel broad-spectrum antifungal agent derived from albaconazole","volume":"4","author":"Guillon","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib41","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1248\/cpb.49.1647","article-title":"Synthesis and in\u00a0vitro antifungal activities of novel triazole antifungal agent CS-758, Chem","volume":"49","author":"Konosu","year":"2001","journal-title":"Pharm. Bull."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114161_bib42","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1248\/cpb.47.1417","article-title":"Synthesis and antifungal activities of (2R,3R)-2-aryl-1-azolyl-3-(substituted amino)-2-butanol derivatives as topical antifungal agents","volume":"47","author":"Ogura","year":"1999","journal-title":"Chem. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114161_bib43","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/jm9707277","article-title":"New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones","volume":"41","author":"Bartroli","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1248\/cpb.46.623","article-title":"Synthesis and antifungal activity of novel thiazole-containing triazole antifungals. II. Optically active ER-30346 and its derivatives","volume":"46","author":"Tsuruoka","year":"1998","journal-title":"Chem. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib45","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1248\/cpb.44.314","article-title":"Optically active antifungal azoles. VI. Synthesis and antifungal activity of N-[(1R, 2r)-2-(2, 4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl)propyl]-N'-(4-substituted phenyl)-3(2H, 4H)-1, 2, 4-triazolones and 5(1H, 4H)-tetrazolones","volume":"44","author":"Kitazaki","year":"1996","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2022.114161_bib46","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.ejmech.2017.10.081","article-title":"Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives","volume":"143","author":"Wu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib47","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s40265-013-0152-x","article-title":"Efinaconazole: first global approval","volume":"73","author":"Patel","year":"2013","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.ejmech.2022.114161_bib48","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/17512433.2015.1083418","article-title":"Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail","volume":"8","author":"Lipner","year":"2015","journal-title":"Expet Rev. Clin. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib49","first-page":"1269","article-title":"Long-term follow-up of onychomycosis patients treated with efinaconazole","volume":"16","author":"Pollak","year":"2017","journal-title":"J.\u00a0Drugs Dermatol. JDD"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114161_bib50","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/ci0496494","article-title":"3D-QSAR and molecular mechanics study for the differences in the azole activity against yeastlike and filamentous fungi and their relation to P450DM inhibition. 1. 3-substituted-4(3H)-quinazolinones","volume":"45","author":"Fratev","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1128\/AAC.42.2.313","article-title":"In\u00a0vitro activity of a new oral triazole, BMS-207147 (ER-30346)","volume":"42","author":"Fung-Tomc","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib52","first-page":"555","article-title":"Ravuconazole eisai\/bristol-myers squibb","volume":"3","author":"Arikan","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"issue":"7","key":"10.1016\/j.ejmech.2022.114161_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.addr.2007.05.013","article-title":"Prodrug strategies to overcome poor water solubility","volume":"59","author":"Stella","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114161_bib54","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.bmcl.2017.03.062","article-title":"Design, synthesis, and in\u00a0vitro evaluation of novel antifungal triazoles","volume":"27","author":"Xie","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/AAC.04613-14","article-title":"Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib56","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1248\/cpb.48.1935","article-title":"Optically active antifungal azoles. X. Synthesis and antifungal activity of N","volume":"48","author":"Kitazaki","year":"2000","journal-title":"Chem. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114161_bib57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389200215666141125121511","article-title":"Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450","volume":"15","author":"Niwa","year":"2014","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2022.114161_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cclet.2013.01.047","article-title":"Design and synthesis of novel antifungal triazole derivatives with good activity and water solubility","volume":"24","author":"Cao","year":"2013","journal-title":"Chin. Chem. Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib59","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/AAC.43.5.1260","article-title":"In\u00a0vitro activity of Syn-2869, a novel triazole agent, against emerging and less common mold pathogens, Antimicrob","volume":"43","author":"Johnson","year":"1999","journal-title":"Agents Chemother"},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib60","first-page":"241","article-title":"Improved laboratory synthesis of YC-071, a potent azole antifungal agent","volume":"41","author":"Zheng","year":"2017","journal-title":"J.\u00a0Chem. Res."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib61","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1128\/AAC.46.5.1388-1393.2002","article-title":"In\u00a0vitro and in\u00a0vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum","volume":"46","author":"Tsuchimori","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/AAC.46.2.283-287.2002","article-title":"Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice","volume":"46","author":"Hayashi","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1248\/cpb.48.694","article-title":"Synthesis and antifungal activities of R-102557 and related dioxane-triazole derivatives","volume":"48","author":"Oida","year":"2000","journal-title":"Chem. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib64","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jfluchem.2005.12.008","article-title":"Substituent effect of fluorine atoms in the 2,4-difluorophenyl group on antifungal activity of CS-758","volume":"127","author":"Kagoshima","year":"2006","journal-title":"J.\u00a0Fluor. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2022.114161_bib65","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1016\/j.bmcl.2003.08.029","article-title":"Phosphonooxymethyl prodrugs of the broad spectrum antifungal azole, ravuconazole: synthesis and biological properties, Bioorg","volume":"13","author":"Ueda","year":"2003","journal-title":"Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114161_bib66","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1517\/13543784.15.6.579","article-title":"Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations","volume":"15","author":"Aperis","year":"2006","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib67","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1248\/cpb.49.1110","article-title":"Optically active antifungal azoles. XIII. Synthesis of stereoisomers and metabolites of 1-[(1R, 2r)-2-(2, 4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-imidazolidinone (TAK-456)","volume":"49","author":"Ichikawa","year":"2001","journal-title":"Chem. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114161_bib68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3797\/scipharm.1501-13","article-title":"Synthesis of isomeric and potent impurities of the triazole-based antifungal drug voriconazole","volume":"83","author":"Sundaram","year":"2015","journal-title":"Sci. Pharm."},{"issue":"20","key":"10.1016\/j.ejmech.2022.114161_bib69","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.tetasy.2009.09.024","article-title":"Enzyme-catalysed approach to the preparation of triazole antifungals: synthesis of (\u2212)-genaconazole","volume":"20","author":"Acetti","year":"2009","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2022.114161_bib70","series-title":"Asymmetric Synthesis of 2-(2, 4-Difluorophenyl)-1-Heterocycl-1-Yl Butan-2, 3-diols","author":"Singh","year":"2000"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114161_bib71","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.5012\/bkcs.2010.31.11.3467","article-title":"Synthesis and activity of novel indole linked triazole derivatives as antifungal agents","volume":"31","author":"Na","year":"2010","journal-title":"Bull. Kor. Chem. Soc."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib72","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1021\/op900065c","article-title":"The process development of ravuconazole: an efficient multikilogram scale preparation of an antifungal agent","volume":"13","author":"Pesti","year":"2009","journal-title":"Org. Process Res. Dev."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib73","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1358\/dot.2015.51.12.2421058","article-title":"Triazole antifungals: a review","volume":"51","author":"Peyton","year":"2015","journal-title":"Drugs Today"},{"issue":"28","key":"10.1016\/j.ejmech.2022.114161_bib74","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/S0040-4039(00)73326-0","article-title":"Novel reactivity of stabilized methylenetributylphosphorane: a new Mitsunobu reagent","volume":"35","author":"Tsunoda","year":"1994","journal-title":"Tetrahedron Lett."},{"issue":"14","key":"10.1016\/j.ejmech.2022.114161_bib75","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/0040-4039(95)00300-2","article-title":"Carbon-carbon bond formation with new Mitsunobu reagents","volume":"36","author":"Tsunoda","year":"1995","journal-title":"Tetrahedron Lett."},{"issue":"14","key":"10.1016\/j.ejmech.2022.114161_bib76","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/0040-4039(96)00319-X","article-title":"Formation of heterocycles by the Mitsunobu reaction. Stereoselective synthesis of (+)-\u03b1-skytanthine","volume":"37","author":"Tsunoda","year":"1996","journal-title":"Tetrahedron Lett."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib77","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1128\/AAC.45.5.1493-1499.2001","article-title":"In\u00a0vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in Guinea pigs","volume":"45","author":"Tatsumi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib78","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1128\/AAC.02063-12","article-title":"Mechanism of action of efinaconazole, a novel triazole antifungal agent","volume":"57","author":"Tatsumi","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114161_bib79","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.tetlet.2007.01.154","article-title":"Direct synthesis of 5-aryltriazole acyclonucleosides via Suzuki coupling in aqueous solution","volume":"48","author":"Zhu","year":"2007","journal-title":"Tetrahedron Lett."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114161_bib80","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.tetlet.2018.02.001","article-title":"Pd-catalyzed Suzuki\/Sonogashira cross-coupling reaction and the direct sp3 arylation of 7-chloro-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidine","volume":"59","author":"Loubidi","year":"2018","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114161_bib81","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1039\/C7RA13321A","article-title":"Recent advances in the application of indoles in multicomponent reactions","volume":"8","author":"Mohammadi Ziarani","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.114161_bib82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejmech.2018.02.065","article-title":"Indole in the target-based design of anticancer agents: a versatile scaffold with diverse mechanisms","volume":"150","author":"Dadashpour","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib83","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bioorg.2017.09.005","article-title":"New indole-based chalconoids as tubulin-targeting antiproliferative agents","volume":"75","author":"Mirzaei","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib84","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bioorg.2015.05.003","article-title":"Synthetic indole Mannich bases: their ability to modulate in\u00a0vitro cellular immunity","volume":"60","author":"Mesaik","year":"2015","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib85","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1021\/acs.oprd.8b00081","article-title":"A\u00a0facile epoxide aminolysis promoted by (t-BuO)2Mg and its application to the synthesis of efinaconazole","volume":"22","author":"Zhu","year":"2018","journal-title":"Org. Process Res. Dev."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib86","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/jo005786y","article-title":"Studies on synthetic approaches to 1H- and 2H-indazolyl derivatives","volume":"66","author":"Isin","year":"2001","journal-title":"J.\u00a0Org. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib87","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.bmcl.2007.03.074","article-title":"Discovery of novel indazole-linked triazoles as antifungal agents","volume":"17","author":"Park","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114161_bib88","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11030-014-9553-3","article-title":"A\u00a0review of syntheses of 1,5-disubstituted tetrazole derivatives","volume":"19","author":"Sarvary","year":"2015","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2022.114161_bib89","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1016\/j.tetlet.2015.11.005","article-title":"Alkylation of 5-substituted NH-tetrazoles by alcohols in the superacid CF3SO3H","volume":"56","author":"Lisakova","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114161_bib90","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1039\/C8OB02089B","article-title":"Efficient synthesis of tetrazole hemiaminal silyl ethers via three-component hemiaminal silylation","volume":"16","author":"Xie","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib91","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1016\/j.bmc.2016.09.066","article-title":"Synthesis of novel tetrazole derivatives and evaluation of their antifungal activity","volume":"24","author":"\u0141ukowska-Chojnacka","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"31","key":"10.1016\/j.ejmech.2022.114161_bib92","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1002\/ejoc.201200469","article-title":"Synthesis and functionalization of 5-substituted tetrazoles","author":"Roh","year":"2012","journal-title":"Eur. J. Org. Chem. 2012"},{"key":"10.1016\/j.ejmech.2022.114161_bib93","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1134\/S1070428020070131","article-title":"Synthesis of precursors to tetrazole monomers by acid-catalyzed alkylation","volume":"56","author":"Egorov","year":"2020","journal-title":"Russ. J. Org. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114161_bib94","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2004.03.004","article-title":"Synthesis of novel substituted tetrazoles having antifungal activity","volume":"39","author":"Upadhayaya","year":"2004","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib95","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ejmech.2015.08.023","article-title":"Design, synthesis, and structure-activity relationship studies of novel thienopyrrolidone derivatives with strong antifungal activity against Aspergillus fumigates","volume":"102","author":"Cao","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114161_bib96","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1016\/j.bmcl.2011.03.096","article-title":"Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinyl carbamates as potent and long acting muscarinic antagonists","volume":"21","author":"Prat","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib97","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cclet.2016.01.040","article-title":"Design and synthesis of novel triazole derivatives containing \u03b3-lactam as potential antifungal agents","volume":"27","author":"Xu","year":"2016","journal-title":"Chin. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib98","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1016\/j.ejmech.2010.09.070","article-title":"Novel conformationally restricted triazole derivatives with potent antifungal activity","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114161_bib99","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1248\/cpb.48.1947","article-title":"Optically active antifungal azoles. XI. An alternative synthetic route for 1-[(1R, 2R)-2-(2, 4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl) propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-2-imidazolidinone (TAK-456) and its analog","volume":"48","author":"Ichikawa","year":"2000","journal-title":"Chem. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1248\/cpb.45.321","volume":"45","author":"Tasaka","year":"1997","journal-title":"Chem. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib101","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1248\/cpb.39.2241","article-title":"Triazole antifungals. III. Stereocontrolled synthesis of an optically active triazolylmethyloxirane precursor to antifungal oxazolidine derivatives","volume":"39","author":"Konosu","year":"1991","journal-title":"Chem. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114161_bib102","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1248\/cpb.49.1102","article-title":"Optically active antifungal azoles. XII. Synthesis and antifungal activity of the water-soluble prodrugs of 1-[(1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl) propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-2-imidazolidinone","volume":"49","author":"Ichikawa","year":"2001","journal-title":"Chem. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1399-3011.1987.tb03327.x","article-title":"Mild, orthogonal solid-phase peptide synthesis: use of N\u03b1-dithiasuccinoyl (Dts) amino acids and N-(iso-propyldithio) carbonylproline, together with p-alkoxybenzyl ester anchoring linkages","volume":"30","author":"Albericio","year":"1987","journal-title":"Int. J. Pept. Protein Res."},{"issue":"22","key":"10.1016\/j.ejmech.2022.114161_bib104","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1080\/00397910500297461","article-title":"Efficient one-step synthesis of a key intermediate for the synthesis of azole antifungals using the Mitsunobu protocol","volume":"35","author":"Sattigeri","year":"2005","journal-title":"Synth. Commun."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114161_bib105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/00397910903014232","article-title":"Synthesis of 2[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-yl)propyl]-4-[4-tetrafluoropropoxy)phenyl]-3-(2H,4H)-1,2,4-triazol-3-thione\u2014a novel and potent azole antifungal agent","volume":"40","author":"Sattigeri","year":"2010","journal-title":"Synth. Commun."},{"issue":"38","key":"10.1016\/j.ejmech.2022.114161_bib106","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/jacs.8b08236","article-title":"anti-Selective catalytic asymmetric nitroaldol reaction of \u03b1-keto esters: intriguing solvent effect, flow reaction, and synthesis of active pharmaceutical ingredients","volume":"140","author":"Karasawa","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114161_bib107","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1142\/S1088424609001406","article-title":"Refined syntheses of hydrodipyrrin precursors to chlorin and bacteriochlorin building blocks","volume":"13","author":"Krayer","year":"2009","journal-title":"J.\u00a0Porphyr. Phthalocyanines"},{"issue":"4","key":"10.1016\/j.ejmech.2022.114161_bib108","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jhet.5570170402","article-title":"Pyrrolo [1, 2-d] triazines-1, 2, 4. II. Etude des pyrrolo [1, 2-d] triazinones-1 et-4","volume":"17","author":"Lancelot","year":"1980","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib109","doi-asserted-by":"crossref","first-page":"112082","DOI":"10.1016\/j.ejmech.2020.112082","article-title":"New azole antifungals with a fused triazinone scaffold","volume":"189","author":"Montoir","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1128\/AAC.46.2.367-370.2002","article-title":"In\u00a0vitro and in\u00a0vivo activities of CS-758 (R-120758), a new triazole antifungal agent","volume":"46","author":"Kamai","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114161_bib111","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.bmcl.2009.02.036","article-title":"Amide analogs of antifungal dioxane-triazole derivatives: synthesis and in\u00a0vitro activities","volume":"19","author":"Uchida","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"24","key":"10.1016\/j.ejmech.2022.114161_bib112","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1016\/j.bmcl.2008.10.055","article-title":"Carbon analogs of antifungal dioxane-triazole derivatives: synthesis and in\u00a0vitro activities","volume":"18","author":"Uchida","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"20","key":"10.1016\/j.ejmech.2022.114161_bib113","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1080\/00397919708007076","article-title":"Practical oxirane ring opening with in situ prepared LiCN; synthesis of (2S, 3r)-3-(2, 4-Difluorophenyl)-3-hydroxy-2-methyl-4-(1 H-1, 2, 4-triazol-1-yl)-1-butanenitrile","volume":"27","author":"Tsuruoka","year":"1997","journal-title":"Synth. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114161_bib114","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1021\/jo00115a014","article-title":"Aldol condensation of evans chiral enolates with acetophenones. Its application to the stereoselective synthesis of homochiral antifungal agents","volume":"60","author":"Bartroli","year":"1995","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib115","author":"Hudyma","year":"2003"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114161_bib116","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/bdd.612","article-title":"Nonclinical pharmacokinetics of BMS-292655, a water-soluble prodrug of the antifungal ravuconazole, Biopharm","volume":"29","author":"Knipe","year":"2008","journal-title":"Drug Dispos"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0732-8893(99)00063-2","article-title":"In\u00a0vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole","volume":"35","author":"Fung-Tomc","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"19","key":"10.1016\/j.ejmech.2022.114161_bib118","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0960-894X(02)00557-7","article-title":"Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals","volume":"12","author":"Ohwada","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib119","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0960-894X(02)00892-2","article-title":"Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole","volume":"13","author":"Ohwada","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114161_bib120","doi-asserted-by":"crossref","first-page":"103982","DOI":"10.1016\/j.bioorg.2020.103982","article-title":"Design, synthesis, and in\u00a0vitro evaluation of novel triazole analogues featuring isoxazole moieties as antifungal agents","volume":"101","author":"Xie","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib121","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.bmcl.2017.06.037","article-title":"Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors","volume":"27","author":"Yates","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114161_bib122","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","author":"Hoekstra","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114161_bib123","first-page":"1","article-title":"Investigational agents for the treatment of resistant yeasts and molds","author":"Seiler","year":"2021","journal-title":"Curr. Fungal Infect. Rep."},{"key":"10.1016\/j.ejmech.2022.114161_bib124","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/AAC.00349-16","article-title":"The investigational drug VT-1129 is a highly potent inhibitor of Cryptococcus species CYP51 but only weakly inhibits the human enzyme","volume":"60","author":"Warrilow","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114161_bib125","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1128\/AAC.02770-15","article-title":"The investigational fungal Cyp51 inhibitor VT-1129 demonstrates potent in\u00a0vitro activity against Cryptococcus neoformans and Cryptococcus gattii","volume":"60","author":"Lockhart","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114161_bib126","first-page":"453","article-title":"Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs","volume":"55","author":"Nielsen","year":"2017","journal-title":"Med. Mycol."},{"key":"10.1016\/j.ejmech.2022.114161_bib127","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01071-18","article-title":"The fungal Cyp51 inhibitor VT-1129 is efficacious in an experimental model of cryptococcal meningitis","volume":"62","author":"Wiederhold","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114161_bib128","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2217\/fmb-2021-0173","article-title":"Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis","volume":"16","author":"Sobel","year":"2021","journal-title":"Future Microbiol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114161_bib129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/jac\/dkx410","article-title":"Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in\u00a0vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus","volume":"73","author":"Wiederhold","year":"2018","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2022.114161_bib130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bmcl.2017.12.040","article-title":"Design, synthesis, and structure-activity relationship studies of novel tetrazole antifungal agents with potent activity, broad antifungal spectrum and high selectivity","volume":"28","author":"Qian","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114161_bib131","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.bmc.2015.02.011","article-title":"Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents","volume":"23","author":"Hashemi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib132","doi-asserted-by":"crossref","first-page":"24981","DOI":"10.1021\/acsomega.1c04016","article-title":"Design, synthesis, and in\u00a0vitro and in\u00a0vivo evaluation of novel fluconazole-based compounds with promising antifungal activities","volume":"6","author":"Shafiei","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2022.114161_bib133","doi-asserted-by":"crossref","first-page":"113524","DOI":"10.1016\/j.ejmech.2021.113524","article-title":"Lanosterol 14\u03b1-demethylase (CYP51)\/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections","volume":"221","author":"Zhu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib134","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1021\/acs.jmedchem.0c00102","article-title":"Discovery of novel fungal lanosterol 14\u03b1-demethylase (CYP51)\/histone deacetylase dual inhibitors to treat azole-resistant candidiasis","volume":"63","author":"Han","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114161_bib135","doi-asserted-by":"crossref","first-page":"112991","DOI":"10.1016\/j.ejmech.2020.112991","article-title":"Novel naphthylamide derivatives as dual-target antifungal inhibitors: design, synthesis and biological evaluation","volume":"210","author":"An","year":"2021","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:34Z","timestamp":1759329514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":135,"alternative-id":["S0223523422000630"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114161","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114161"}}